Please login to the form below

Not currently logged in
Email:
Password:

Rosetta merges with Razorfish Healthware to launch new agency

Merger will create Razorfish Health
Razorfish logo

Publicis Healthcare Communications Group (PHCG) has revealed that part of Rosetta's healthcare business is to merge into Razorfish Healthware to create Razorfish Health.

The engagement, creative and media segment of Rosetta's healthcare business will merge in the US with PHCG's existing agency, Razorfish Healthware.

Nick Colucci, CEO of PHCG, commented: “As health and wellness clients grapple with the accelerating transformation of healthcare in a digital world, the new Razorfish Health is ideally positioned to bring its combined expertise in engagement, innovation and technology to deliver better health outcomes for our clients.”

Rosetta's healthcare business, in regards to commerce, enterprise technology platforms and growth strategy consulting will remain at Rosetta under its East Region.
Shannon Hartley, previous leader of Rosetta's Healthcare Industry Group, will take the role of managing director of Razorfish Health, taking over US operations.

The new agency will report to PHCG president Janet Winkler, who additionally oversees North American operations of Saatchi & Saatchi Wellness, in-sync Customer Insights, Discovery USA, Maxcess and Verilogue.

Article by
Kirstie Pickering

25th February 2015

From: Sales, Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....